{"id":"W1976338840","doi":"10.1016/j.pupt.2011.10.002","title":"Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension","year":2011,"lang":"en","type":"article","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Actelion Pharmaceuticals; Bayer Canada; United Therapeutics Corporation; Pfizer","keywords":"Medicine; Placebo; Peripheral edema; Adverse effect; Nausea; Clinical endpoint; Anesthesia; Internal medicine; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001351642,0.0002878098,0.0005441332,0.0002410347,0.0000988668,0.000004649094,0.00009325199,0.0001495275,0.0001658906],"category_scores_gemma":[0.000003726257,0.0002135133,0.00004883058,0.0002025575,0.0004180382,0.0001332896,0.0001177583,0.0002846045,0.000007331338],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004535686,"about_ca_system_score_gemma":0.00006931065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006343306,"about_ca_topic_score_gemma":0.00000295129,"domain_scores_codex":[0.9982949,0.0001564352,0.0003723731,0.000449882,0.0002823236,0.0004440592],"domain_scores_gemma":[0.9991428,0.0001313601,0.0001086276,0.0002238946,0.0001282503,0.0002650281],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04192219,0.007184622,0.8375819,0.00007621564,0.0004743472,0.002894279,0.0001602421,6.111655e-7,0.06382449,0.000006213472,0.00002221254,0.04585266],"study_design_scores_gemma":[0.009647677,0.001805999,0.9832687,0.0000627553,0.0006077607,0.0005552581,0.00008379148,0.0004181211,0.001638677,0.00004561221,0.001669898,0.0001957245],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962503,0.00144347,0.000002844586,0.0004715931,0.0001376072,0.0009079652,0.00003401358,0.0000302924,0.0007219059],"genre_scores_gemma":[0.9964954,0.001666324,0.000338007,0.001240854,0.00004913713,0.00001796828,0.00007591542,0.00003917144,0.00007727426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1456868,"threshold_uncertainty_score":0.8706821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03833353606268927,"score_gpt":0.288309320125465,"score_spread":0.2499757840627757,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}